US equities
|
MU
$1,078.50
▲+3.15%
NVDA
$237.19
▼-0.85%
SNDK
$1,722.38
▲+3.73%
AMD
$644.26
▼-0.79%
SPCX
$169.19
▼-1.59%
INTC
$113.35
▲+0.76%
TSLA
$375.74
▼-1.30%
AAPL
$334.83
▲+0.36%
MU
$1,078.50
▲+3.15%
NVDA
$237.19
▼-0.85%
SNDK
$1,722.38
▲+3.73%
AMD
$644.26
▼-0.79%
SPCX
$169.19
▼-1.59%
INTC
$113.35
▲+0.76%
TSLA
$375.74
▼-1.30%
AAPL
$334.83
▲+0.36%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Albrioza
Recent news which mentions Albrioza
Canada Approves Amylyx's ALS Drug; FDA To Consider Approval In September
June 13, 2022
Tickers
ALS
AMLX
Tags
Canada
AMLX
ALS
From
Benzinga